New blood vessels are initially formed through the assembly or sprouting of endothelial cells, but the recruitment of supporting pericytes and vascular smooth muscle cells (mural cells) ensures the formation of a mature and stable vascular network. Defective mural-cell coverage is associated with the poorly organized and leaky vasculature seen in tumors or other human diseases. Here we report that mural cells require ephrin-B2, a ligand for Eph receptor tyrosine kinases, for normal association with smalldiameter blood vessels (microvessels). Tissue-specific mutant mice display perinatal lethality; vascular defects in skin, lung, gastrointestinal tract, and kidney glomeruli; and abnormal migration of smooth muscle cells to lymphatic capillaries. Cultured ephrin-B2-deficient smooth muscle cells are defective in spreading, focal-adhesion formation, and polarized migration and show increased motility. Our results indicate that the role of ephrin-B2 and EphB receptors in these processes involves Crk-p130(CAS) signaling and suggest that ephrin-B2 has some cell-cell-contact-independent functions.
SUMMARY
New blood vessels are initially formed through the assembly or sprouting of endothelial cells, but the recruitment of supporting pericytes and vascular smooth muscle cells (mural cells) ensures the formation of a mature and stable vascular network. Defective mural-cell coverage is associated with the poorly organized and leaky vasculature seen in tumors or other human diseases. Here we report that mural cells require ephrin-B2, a ligand for Eph receptor tyrosine kinases, for normal association with smalldiameter blood vessels (microvessels). Tissue-specific mutant mice display perinatal lethality; vascular defects in skin, lung, gastrointestinal tract, and kidney glomeruli; and abnormal migration of smooth muscle cells to lymphatic capillaries. Cultured ephrin-B2-deficient smooth muscle cells are defective in spreading, focal-adhesion formation, and polarized migration and show increased motility. Our results indicate that the role of ephrin-B2 and EphB receptors in these processes involves Crk-p130(CAS) signaling and suggest that ephrin-B2 has some cell-cell-contact-independent functions.
INTRODUCTION
The coordinated generation of different cell types and their organization into functional structures are key processes during tissue morphogenesis. In the cardiovascular system, endothelial cells (ECs) that form the inner lining of blood vessels need to recruit different types of mural cells to form stable and functional structures (Carmeliet, 2003; Gerhardt et al., 2003; Jain, 2003) . Pericytes (PCs), which share the basal lamina with the endothelium, extend numerous cellular processes that are in direct contact with ECs. This interaction leads to a quiescent phenotype of the vasculature (i.e., the formation of new endothelial sprouts is suppressed) and prevents leakage through the vessel wall by reducing the permeability of the endothelial monolayer. Pericytes are confined to newly formed vascular structures, capillaries, and postcapillary venules. In contrast, larger blood vessels are covered by vascular smooth muscle cells (vSMCs) , which attach in one or multiple layers to the external (abluminal) side of the endothelial basal lamina. vSMCs produce extracellular matrix and elastic fibers that provide vessels with the necessary structural stability and elasticity. Both mural-cell types have been linked to human pathologies: The loss of pericyte coverage in the retinae of diabetic patients leads to increased vascular permeability, aberrant endothelial sprouting, and, ultimately, blindness (Adamis et al., 1999; Betsholtz et al., 2005) . Lesions in the smooth muscle cell layer and abnormal vSMC migration can block blood flow through arteries in atherosclerosis (Faxon et al., 2004) . The molecular mechanisms mediating endothelial-mural interactions are incompletely understood, but previous work has highlighted the importance of transforming growth factor b, sphingosine 1-phosphate, angiopoietin-1, platelet-derived growth factor B (PDGF-B), and their respective receptors in this process (Betsholtz et al., 2005; Jain, 2003) .
Eph receptor tyrosine kinases (RTKs) and their cell-surfaceanchored ephrin ligands are versatile regulators of tissue morphogenesis and blood-vessel formation. Ephrin-B2, a transmembrane protein with a short cytoplasmic tail, is predominantly expressed on arterial ECs in several vertebrate species, whereas one of its binding partners, the receptor EphB4, is largely confined to veins (Adams et al., 1999 ; Figure 1 . Phenotype of PC/vSMC-Specific Efnb2 Mutants (A-E) Expression of ephrin-B2 in arterial and venous mural cells. Immunofluorescence on sections of E17.5 wild-type mesenteric artery (a) and vein (v) with antibodies recognizing EphB4 (A) or ephrin-B2 (B) (green) and a-smooth muscle actin (a-SMA, red). Ephrin-B2 protein is present on arterial ECs and, at lower level, on arterial and venous mural cells. Similar patterns were seen in the mesentery of Efnb2-lacZ (Wang et al., 1998) (N-S) Hematoxylin and eosin (H&E) stained tissue sections from mutant and control E18.5 embryos as indicated. Gerety et al., 1999; Wang et al., 1998) . Gene targeting experiments in mice have demonstrated that ephrin-B2 (encoded by the gene Efnb2) and EphB4 (Ephb4) are equally essential for the angiogenic remodeling of blood vessels in the early embryo, which suggests that they mediate vascular morphogenesis through reciprocal interactions and bidirectional signaling (Adams et al., 1999; Gerety et al., 1999; Wang et al., 1998) . The lethality of these global knockouts seems to indicate an essential function in the endothelium because ECspecific inactivation of Efnb2 is also incompatible with embryonic angiogenesis and survival beyond midgestation (Gerety and Anderson, 2002) . However, ephrin-B2 is also expressed in a range of other cell types and tissues such as PCs and vSMCs (Gale et al., 2001; Shin et al., 2001) , but the early lethality of the existing mutant mouse models has so far limited functional studies in vivo. Therefore, we have employed a conditional gene targeting (Cre-loxP) approach to selectively disrupt expression of the ligand in pericytes and vSMCs.
RESULTS

Mural-Cell-Specific Inactivation of Efnb2
In the developing vascular system, ephrin-B2 is expressed in the arterial endothelium, where its expression is highest, as well as in the mural cells covering arteries and veins ( Figures  1A-1E ). To study the role of the Eph RTK ligand in pericytes and vSMCs, transgenic Pdgfrb-Cre mice (S.S.F. and R.H.A., unpublished data), which express Cre recombinase under the control of a fragment of the gene encoding plateletderived growth factor receptor PDGFRb, were bred into a background of mice carrying a loxP-flanked version of the Efnb2 gene (Efnb2 lox/lox ) (Grunwald et al., 2004) . This approach directs Efnb2 inactivation to mural cells in many organs, including skin, intestine, kidney, lung, and the vascular plexus surrounding the central nervous system (see Figure S1 in the Supplemental Data available with this article online). The resulting Efnb2 DPC/vSMC mutants develop to term but die shortly after birth due to respiratory failure (data not shown). Freshly isolated embryos at embryonic day 18.5 (E18.5) display edema and extensive hemorrhaging in the skin ( Figures 1F-1I ). The absence of ephrin-B2 protein in Efnb2 DPC/vSMC smooth muscle cells was confirmed by immunofluorescence on tissue sections ( Figures 1J and 1K) . Furthermore, genotyping of freshly isolated endothelial cells verified the integrity of the loxP-flanked gene fragment in isolated endothelial cells from Efnb2 DPC/vSMC heterozygotes ( Figure S1 ). EphB4 protein equally marks veins in Efnb2 DPC/vSMC and control tissues, indicating that mutant blood vessels adopt normal arterial-venous identities (data not shown).
In addition to the defects in mutant skin described above, mural-cell-specific loss of ephrin-B2 affects a range of organs. Freshly isolated intestines are pale and mesenteric lymphatics are filled with red blood cells, indicating hemorrhage ( Figures 1L and 1M ). Sectioning of intestinal walls revealed the presence of large blood-filled spaces ( Figures  1N and 1O) . In mutant kidneys, comma-and S-shaped bodies develop normally, but the more mature glomerular tufts, formed by capillaries and mesangial cells, are poorly organized ( Figures 1P and 1Q) . Hemorrhaging in the lungs of Efnb2 DPC/vSMC embryos provides a possible explanation for the respiratory arrest observed at birth ( Figures 1R and 1S ).
Loss of Ephrin-B2 Disrupts Microvessel Architecture
The characterization of Pdgfb and Pdgfrb knockout mice has established that insufficient proliferation and recruitment of PCs/vSMCs leads to compromised integrity of blood vessels in skin and mesentery, disorganization of kidney glomeruli, and perinatal lethality similar to what we observed for Efnb2 DPC/vSMC mutants (Hellstrom et al., 1999; Lindahl et al., 1998; Soriano, 1994) . However, we found that the number of vSMCs and PCs covering the Efnb2 DPC/vSMC mutant vasculature is comparable to control tissues ( Figure S2 ).
Since mural-cell numbers fail to provide an explanation for the defects in the Efnb2 DPC/vSMC vasculature, we examined the spatial organization of pericytes and vSMCs associated with microvessels at high resolution. We found that smooth muscle cells are scattered, resulting in an incomplete coverage of microvessels (Figures 2A and 2B ). The presence of rounded vSMCs suggests that these cells require ephrin-B2 for proper spreading and attachment ( Figures 2C and  2D ). Similarly, pericytes, which normally wrap tightly around capillaries, show diminished interaction with microvessels in Efnb2 DPC/vSMC embryos. Frequently, mutant PCs bridge two capillaries, make only loose contact with ECs, stretch away from vessels, or appear rounded ( Figures 2E-2I ). On the ultrastructural level, Efnb2 DPC/vSMC pericytes associate poorly with capillaries, and abnormal deposits of extracellular matrix can be seen in gaps separating PCs from the endothelium ( Figures 2L-2O ). Mutant vessels are frequently ruptured and release blood cells into the surrounding tissue ( Figure 2P ). Furthermore, excessive deposits of collagen fibers are found in the proximity of mutant mural cells ( Figure 2Q ).
Ephrin-B2 Is Required for Directional Migration and Cell-Matrix Interactions
To study the molecular nature of the Efnb2 DPC/vSMC phenotype, we established an aortic smooth muscle cell line from mice carrying two copies of the loxP-flanked Efnb2 allele (see Experimental Procedures). These cells show robust levels of ephrin-B2 protein as well as expression of the receptors EphB2, EphB3, and EphB4 ( Figure 3A and receptors (data not shown). Next, we generated ephrin-B2-deficient (Dephrin-B2) and control cells by transfecting cultured vSMCs with a Cre expression construct or empty vector, respectively (see Experimental Procedures). As expected, the loxP-flanked Efnb2 gene section is deleted (Figure S3 ) and ephrin-B2 protein expression is absent in Dephrin-B2 cells ( Figure 3B ). Tyrosine-phosphorylated EphB4 receptor is readily detectable in control SMCs, whereas activation of the receptor is absent in cells lacking ephrin-B2. However, stimulation of Dephrin-B2 cells with soluble recombinant ephrin-B2 fusion proteins leads to robust binding and EphB4 phosphorylation ( Figure 3C and Figure S3 ).
Loss of ephrin-B2 leads to striking morphological changes: (1) The cells are elongated and insufficiently spread, (2) they show numerous lamellipodial protrusions in a nonpolarized fashion, and (3) cell detachment at the rear end is compromised ( Figures 3D and 3E ). Live video microscopy (see Experimental Procedures) revealed that Dephrin-B2 lamellipodia are highly instable and tend to collapse after short phases of rapid extension. New lamellipodia are constantly formed in other parts of the cells, resulting in frequent changes of direction, random but accelerated movement, and poor spreading ( Figure S4 ; Movies S1 and S2). Surprisingly, Dephrin-B2 cells show this behavior in low-density cultures in a cell-cell-contact-independent (autonomous) fashion. In scratch assays (i.e., the wounding of confluent cell layers), ephrin-B2-deficient vSMCs migrate faster but more randomly than control cells (data not shown). After the closing of the scratch wounds, control vSMCs display reduced motility, whereas Dephrin-B2 cells continue to migrate actively, indicating that cell-cell-contact-dependent interactions through ephrin-B2 inhibit cell migration (Movies S3 and S4). The abnormal morphology and motility of Dephrin-B2 cells does not obviously correlate with cytoskeletal defects, as tubulin microfilaments, actin stress fibers in the cell body, and the F-actin network at the leading edge of lamellipodia can be formed ( Figure S2 ). In contrast, cell-matrix contacts, visible as focal adhesions (FAs), are dramatically altered in the absence of ephrin-B2. Control vSMCs exhibit numerous focal adhesions in both the periphery and the center, whereas central FAs are reduced in Dephrin-B2 cells (Figures 3F and  3G) . Likewise, FAs and more immature focal contacts are abundant in control lamellipodial protrusions but are sparse or missing in the absence of ephrin-B2 (Figures 3H and 3I) . Dephrin-B2 peripheral focal adhesions appear enlarged and irregular ( Figures 3J and 3K) . Similar defects were seen in cells cultured on fibronectin, collagen, or laminin substrates ( Figure S3 ).
To observe dynamic changes affecting FA formation and turnover, we studied migrating cells using live confocal interference reflection microscopy (IRM; see Experimental Procedures). This method showed that control cells constantly form new FAs behind their leading edge and progress steadily across these cell-matrix contacts. In contrast, very few or no FAs form within Dephrin-B2 lamellipodia ( Figures  3L and 3M ; Movies S5 and S6). Focal adhesions are large protein complexes assembled around activated integrin receptors (Mitra et al., 2005; Wehrle-Haller and Imhof, 2002) . In the lamellipodia of control vSMCs, integrin a5, which forms functional integrin heterodimers with the b1 subunit, overlaps with other FA components in numerous structures of different size. Such sites of integrin-mediated cell-matrix adhesion are rare in Dephrin-B2 cells (Figures 3N and 3O) . Moreover, focal complexes, small and immature cell-matrix interaction sites, show reduced activation of focal adhesion kinase (FAK), indicating that Dephrin-B2 cells may be defective in the maturation of FAs at the migration front ( Figures 3N  and 3O ). In this context, it is noteworthy that processes occurring within the Dephrin-B2 leading edge appear unaffected, i.e., FAK, paxillin, and other FA proteins are present as in control cells ( Figures 3N and 3O and data not shown).
Despite the abnormal shape of Dephrin-B2 peripheral FAs, integrins are capable of signaling in response to matrix engagement in these structures: FAK is activated, vinculin and paxillin are recruited, and the adaptor molecules CrkL/CrkII and p130(CAS) are present ( Figures 3P-3S and data not shown).
The defects described above can be rescued by reexpressing ephrin-B2 ( Figures 3T and 3U) . Similarly, expression of an activated version of Tiam1 (T-lymphoma invasion and metastasis), an activator for the Rho-like GTPase Rac1, restores spreading and (to some extent) FA formation in Dephrin-B2 cells ( Figure 3V ).
Role of Ephrin-B2 in Focal-Adhesion Formation and Motility
To address the question of how ephrin-B2 can control FA formation and motility, we monitored vSMCs after stimulation with soluble recombinant ephrin-B2/Fc or EphB4/Fc fusion proteins by live IRM (see Experimental Procedures). Prior to stimulation, control vSMCs move in a steady fashion involving the constant formation of new FAs behind the leading edge. Internal FAs are also readily visible in the reflection images (Movie S7). Within minutes after activation of endogenous EphB receptors with ephrin-B2/Fc, cells stop moving, although the peripheral membrane continues to ruffle. Focal adhesions reorganize significantly in the following hour, as internal FAs are reduced (or eliminated) whereas peripheral FAs are strengthened in areas of both cell expansion and retraction ( Figure 4A ; Movie S7). Cell migration is also reduced after treatment with EphB4 or ephrin-B2 fusion proteins in transwell assays ( Figure S5) .
What are the signaling processes that might link ephrin-B2 and its receptors, which themselves show no obvious FA localization ( Figures 5G, 5L, and 5N) , to focal-adhesion organization and motility? The Crk-family proteins CrkII and CrkL, cytoplasmic adapters composed of Src homology SH2 and SH3 domains, are important regulators of cell migration and FA formation. Complexes between Crk proteins and Crkassociated substrate p130(CAS) interconnect integrin and growth factor receptor signaling by promoting local Rac GTPase activation, actin dynamics, and the formation of lamellipodial protrusions (Chodniewicz and Klemke, 2004) . The activity of Crk-p130(CAS) complexes is tightly regulated by tyrosine kinases and phosphatases: Phosphorylation of Crk blocks its association with p130(CAS) but also promotes translocation of the protein within the cell. In turn, a series of tyrosine residues within p130(CAS) require phosphorylation by kinases (such as FAK or Src) for Crk binding. Several protein tyrosine phosphatases (PTPs) also control Crk and p130(CAS) activity through dephosphorylation of these proteins (Chodniewicz and Klemke, 2004) . Since previous work has linked Eph-ephrin signaling and Crk-mediated regulation of cell adhesion and membrane ruffling (Lawrenson et al., 2002; Nagashima et al., 2002; Sakamoto et al., 2004) , we checked whether loss of ephrin-B2 leads to alterations in this pathway. Indeed, Crk-p130(CAS) association is increased in Dephrin-B2 SMCs, consistent with the enhanced motility of these cells ( Figure 4B ). At the same time, tyrosine phosphorylation of Crk-associated p130(CAS) is reduced, suggesting that the complex of these proteins might be less stable than in control cells ( Figure 4B ). As Src, one of the kinases involved in p130(CAS) phosphorylation, is activated downstream of EphB/ephrin-B molecules (Figures 4D-4F ; Palmer et al., 2002; Zisch et al., 1998) , it is possible that the lack of ephrin-B2 compromises this pathway. However, other explanations, such as increased PTP activity, appear equally feasible.
Alterations in Dephrin-B2 cells may also directly involve Crk-family proteins. siRNA-mediated reduction of Crk protein levels significantly decreases the migration speed of Dephrin-B2 SMCs, indicating that Crk is rate limiting for the motility of these cells ( Figure S5 and Movies S11-S14). Reduced motility of SMCs after stimulation with ephrin-B2/Fc or EphB4/Fc is accompanied by changes in the distribution patterns of phospho-CrkL (P-CrkL) and phospho-CrkII (Figure 4G , Figure S5 , and data not shown). Antibody signals increase at peripheral FAs, hinting at phosphorylation/ dephosphorylation or protein translocation events. Clusters of internalized ephrin-B2/Fc, but not EphB4/Fc, show extensive overlap with phosphorylated CrkL and CrkII (Figures 4H and 4I and data not shown). This may be caused by Crk translocation because biochemical analysis of stimulated cells provides no evidence for changes in total P-Crk levels ( Figure 4C ). Moreover, Dephrin-B2 cells, in which P-CrkL/ CrkII signals are almost exclusively located to peripheral FAs, show very little overlap with ephrin-B2/Fc after stimulation ( Figures 4H and 4I) .
Not only does treatment of control vSMCs with ephrin-B2/ Fc or EphB4/Fc lead to relatively rapid changes in the FA pattern, but hours after stimulation, the cells also display increasingly altered motility. Most notably, these SMCs are poorly spread and abnormally shaped, and movements fail to translate into directional migration. New lamellipodia are formed in quick succession but tend to be short lived (Figures 5A-5C ; Movies S8-S10). As this behavior mimics Dephrin-B2 cells, we studied the fate of endogenous ephrin-B2 protein in the hours following stimulation with EphB4/Fc. Between 0.5 and 2.5 hr, the ligand is successively internalized and accumulated in the perinuclear region. At 6.5 hr posttreatment, ephrin-B2 has been degraded almost entirely so that the remaining signal is comparable to the unspecific background seen in Dephrin-B2 cells ( Figures  5D-5K ). Moreover, ephrin-B2/Fc or EphB4/Fc binding is absent 4 hr after cells have been prestimulated with the same fusion protein ( Figure 5L-5O ), whereas binding capacity is retained after 4 hr when cells were only transiently stimulated for 1 hr (data not shown). Thus, the stimulation of vSMCs with ephrin-B2/Fc or EphB4/Fc leads to a transient period of signaling that is followed by a longer phase of protein degradation/depletion. The latter phenocopies aspects of the loss-of-function situation seen in Dephrin-B2 cells.
Mural-Cell Attachment and Motility In Vivo
Reminiscent of the motility and adhesion defects in cultured Dephrin-B2 vSMCs, mural cells in Efnb2 DPC/vSMC mutant mice fail to attach properly to the blood-vessel endothelium and are frequently scattered around microvascular beds (Figures 2A and 2B and Figures 6A and 6B) . We also observed that Efnb2 DPC/vSMC vSMCs cover large-diameter PECAM-1-positive vessels in the skin, which were identified as part of the lymphatic vasculature by staining with anti-LYVE1 antibodies (Figures 6C-6G ). These distal lymphatics are essential for the removal of excess interstitial fluid and extravasated molecules from the skin and are normally not covered by smooth muscle (Oliver and Detmar, 2002; Pepper and Skobe, 2003; Saharinen and Petrova, 2004) . Closer examination showed that some Efnb2 DPC/vSMC a-SMApositive cells are bridging blood vessels and lymphatics in mutants, indicative of cells moving from one type of vessel to another ( Figure 6H) .
Recent work has established that ectopic expression of PDGF-B by lymphatic vessels in mice lacking the forkhead transcription factor FoxC2 leads to abnormal recruitment of mural cells . We found that distal lymphatics in the skin of mice lacking PDGFRb also carry a-SMA-positive cells, although the overall numbers of mural cells is dramatically reduced (Figures 6I and 6J ). This suggests that the ability to sense the chemotactic signal PDGF-B (provided by the blood-vessel endothelium) prevents aberrant migration of mural cells. Similarly, increased but random motility might allow ephrin-B2-deficient vSMCs to leave blood vessels and occupy lymphatic capillaries (Figures 6E-6H ).
DISCUSSION
Vascular morphogenesis involves the generation of endothelial and mural cells, their migration to the proper locations, and, finally, their assembly into functional structures. Here we show that ephrin-B2, a cell-surface-anchored ligand for Eph RTKs, is a critical regulator of mural-cell migration, spreading, and adhesion during blood-vessel-wall assembly. Surprisingly, the defects displayed by ephrin-B2-deficient cells indicate that the ligand has cell-autonomous and cellcell-contact-dependent functions, both of which may be required for normal tissue morphogenesis.
Blood-Vessel-Wall Assembly
The Efnb2 DPC/vSMC phenotype is best summarized as the inability of mural cells to get functionally incorporated into the wall of blood vessels: Ephrin-B2-deficient pericytes make insufficient contacts with ECs, fail to envelope the endothelial monolayer, and remain only loosely attached. Mutant vSMCs appear poorly attached, cover small-diameter blood vessels in a discontinuous fashion, and ectopically occupy lymphatic capillaries in the skin. Although it is unclear whether all these abnormally distributed cells are exclusively vSMCs-previous work has shown that detaching pericytes express a-SMA (Morikawa et al., 2002) 
-defects in Efnb2
DPC/vSMC mice are not confined to any one of the two mural-cell subclasses. This is significant because pericytes and vSMCs associate with blood vessels in fundamentally different ways: PCs make direct contact with ECs, whereas vSMCs are associated with the abluminal side of the basement membrane. We propose that ephrin-B2 controls interactions between mural cells as well as between pericytes and the endothelium ( Figure 7A ). These interactions may reduce the migration of PCs/vSMCs and ensure that they cover maturing vascular beds adequately and stably. Expression patterns of the relevant players in vivo are consistent with such a role: RT-PCR on freshly isolated Pdgfrb-Cre-positive mural cells confirms the expression of several EphB receptors ( Figure S6 ). Efnb2-lacZ reporter expression is comparably low and heterogeneous in microvascular beds but increases with vessel diameter and can be most robustly seen on larger arteries. EphB2, detected with an Ephb2-lacZ knockin reporter (Henkemeyer et al., 1996) , is also present in the mural cells coating larger vessels (mainly arteries) in a range of tissues ( Figure S6 ). Immunohistochemistry data indicate that mural cells similarly express the receptor EphB3 in a hierarchical fashion (data not shown). Thus, mural ephrin-B2 and EphB RTK expression correlates with blood-vessel maturation, and the phenotype of Efnb2 mutants may reflect a role in this process.
Another aspect of the Efnb2 DPC/vSMC phenotype is that it almost exclusively affects the architecture of microvessels, whereas large-caliber blood vessels show only minor defects (data not shown). This may reflect the higher sensitivity of the more recently formed and therefore less mature microvessels and is similar to findings in Pdgfb mutants (Hellstrom et al., 1999) . Remarkably, Efnb2
DPC/vSMC mice have other features in common with mutants in the PDGF-B/PDGFRb pathway: Malformations affect similar tissues (e.g., skin, kidney, intestine), and the loose attachment of ephrin-B2-deficient pericytes phenocopies defects in mutant mice expressing a truncated (and more diffusible) form of PDGF-B (Lindblom et al., 2003) . Misexpression of PDGF-B by lymphatic vessels leads to abnormal vSMC recruitment in mice lacking the forkhead transcription factor FoxC2 and has been linked to the human disease lymphedema distichiasis . Efnb2 and Pdgfrb mutants display ectopic vSMC coverage on lymphatic capillaries, indicating that both pathways provide important signals guiding mural cells to the correct targets. Future work will seek to address whether these signals act independently or in combination.
Role of Ephrin-B2 in Cell Spreading, Adhesion, and Migration Our analysis of cultured SMCs shows that ephrin-B2 controls focal-adhesion formation, cell adhesion, spreading, and directional migration ( Figure 7B) . What is the nature of the link between Eph/ephrin molecules and these cellular processes? Previous studies have proposed that Eph-ephrin interactions modulate integrin-mediated adhesion and cell migration through FAK or Src kinases, the adaptor molecules Crk and p130(CAS), and Rho-family GTPases (Carter et al., 2002; Deroanne et al., 2003; Huai and Drescher, 2001; Huynh-Do et al., 2002; Miao et al., 2005; Nagashima et al., 2002; Sakamoto et al., 2004) . Our own data point at complexes of Crk adaptor proteins and p130(CAS), which promote cell motility and spreading and the growth of lamellipodial protrusions (Chodniewicz and Klemke, 2004) . Crkp130(CAS) association is increased in Dephrin-B2 SMCs, which is consistent with the increased motility and the rapid extension of protrusions, whereas the phosphorylation of tyrosine residues in the stretch of 15 SH2 domain-docking motifs of p130(CAS) is reduced. These two findings may appear contradictory at first glance-only phosphorylated CAS can bind to Crk-but it is also known that a small subset of the SH2 binding sites is sufficient for Crk association and migration of mouse embryonic fibroblasts (Shin et al., 2004) . Nevertheless, as the extent of p130(CAS) tyrosine phosphorylation positively correlates with binding capacity (Shin et al., 2004) , the complex with Crk proteins might be less stable and therefore more short lived in the absence of ephrin-B2. Our results also indicate that the distribution and/or local phosphorylation of Crk-family proteins may be regulated through EphB/ephrin-B2 molecules. For example, stimulated cells show phospho-CrkL/CrkII accumulation at clusters of internalized ephrin-B2/Fc (i.e., bound Eph receptors) as well as at peripheral focal adhesions.
The sum of our results indicates that Crk-p130(CAS) signaling is a key pathway downstream of EphB/ephrin-B2 molecules ( Figure 7B ), which does not rule out some contribution of other molecular players.
Cell-Autonomous Function of Ephrin-B2
One of the most surprising findings in our studies, the abnormal morphology and motility of Dephrin-B2 cells in the absence of cell-cell interactions, leads to the question of how the ligand may function in a cell-autonomous mode. Is this process based on receptor-independent signaling, or does it involve interactions with receptors in the same cell? Our observation that long-term stimulation of cells with EphB4/Fc or ephrin-B2/Fc fusion protein leads to the depletion of the corresponding binding partners (presumably through internalization and degradation of signaling complexes) provides a clue that manipulation of EphB RTKs can lead to cell defects similar to the loss/depletion of ephrin-B2. Consequently, there may be some level of Eph-ephrin signaling even in absence of contact with other cells. Such receptorligand interactions in cis are supported by previous reports showing that coexpression of EphA/ephrin-A molecules in the same cell can lead to the masking of binding sites available for interactions in trans (Hornberger et al., 1999; Yin et al., 2004) . In contrast, Marquardt et al. (2005) have recently proposed that EphAs and ephrin-As function independently from distinct membrane domains. We currently have no evidence for the compartmentalized distribution of ephrin-B2 and EphB RTKs in the plasma membrane or masking by interactions in cis. However, it is also possible that molecules might interact in trans within the same cell-for example, at membrane ruffles, in the Golgi apparatus, or in endocytic compartments. Irrespective of the exact mechanism, the striking abnormalities seen in isolated Dephrin-B2 cells appear more compatible with a role in cell-autonomous signaling than the masking of EphB receptors. However, the latter may be still relevant in settings involving cell-cell contacts such as interactions between PCs and ephrin-B2-expressing ECs or between neighboring mural cells ( Figure 7B ).
Implications for Ephrin-B2 in Disease
Whereas research over many years has established roles for Eph/ephrin molecules in a range of developmental processes, significantly less is known about pathological conditions. Several of our results hint at a possible involvement of ephrin-B2 in disease processes. (1) Compromised muralcell coverage and vascular integrity in Efnb2 DPC/vSMC mice recapitulate aspects of the pericyte loss in the retinae of diabetic patients, which leads to the ballooning of capillaries (microaneurysms), high vascular permeability, ectopic sprouting of blood vessels, and blindness (Adamis et al., 1999; Betsholtz et al., 2005) . (2) Tumor blood vessels are frequently disorganized, leaky, and poorly functional. These defects may involve loose association of pericytes (Morikawa et al., 2002) similar to defects in Efnb2 DPC/vSMC mutants.
(3) Altered expression of Eph receptors and ephrins has been also linked to cancer cell invasion and malignancy (Andres and Ziemiecki, 2003; Brantley-Sieders et al., 2004) and may affect cancer cell motility, invasion and metastasis.
Future genetic experiments, such as spatially and temporally controlled gene inactivation, will address the role of ephrin-B2 in animal models of human diseases without compromising essential roles during developmental tissue morphogenesis.
EXPERIMENTAL PROCEDURES
Generation of Mutant Mice
Pdgfrb-Cre transgenic mice were generated by pronuclear injection of a Pdgfrb gene fragment (S.S.F. and R.H.A., unpublished data) and a cDNA encoding Cre recombinase followed by an SV40 polyadenylation signal. Cre activity of transgenic founders was characterized in a ROSA26 Cre reporter background (Soriano, 1999) . Pdgfrb-Cre and Efnb2 conditional mice (Grunwald et al., 2004) were bred to generate Efnb2 DPC/vSMC mutants. Cre-negative littermates were used as controls. Animals were in a mixed 129 Â C57BL/6 genetic background. See Supplemental Data for details of breeding, genotyping, and RT-PCR analysis.
Staining of Tissues and Tissue Sections
Freshly isolated embryos or tissues were frozen in liquid nitrogen, embedded in OCT compound, and sectioned (5 mm) with a Bright cryostat. Alternatively, samples were fixed overnight in 4% paraformaldehyde at 4ºC or zinc fixative (0.1 M Tris [pH 7.4], 0.5 g/l calcium acetate, 5 g/l zinc acetate, 5 g/l zinc chloride) at room temperature overnight followed by embedding and sectioning in paraffin. Selected paraffin sections were stained with hematoxylin and eosin using standard protocols. See Supplemental Data for details of antibody stainings. For b-galactosidase staining, tissues were dissected from E18.5 embryos, fixed in 0.25% glutaraldehyde/PBS (5 min), and stained as previously described (Compagni et al., 2003) .
Electron Microscopy
Skin samples were fixed in 2.5% glutaraldehyde in Sorensen's phosphate buffer (pH 7.4), postfixed in osmium tetroxide in the same buffer, and embedded in araldite. Sections were cut on a Reichert Ultracut, stained with lead citrate and uranyl acetate, and viewed in a JEOL 1010.
SMC Culture
Aortas from adult Efnb2 lox/lox homozygotes carrying the ''immorto'' transgene (Supplemental Data) were isolated and placed in DMEM. After removal of the adventitial layer, aortas were cut longitudinally into 5 Â 5 mm pieces, placed in six-well dishes (luminal side touching the plastic), and cultured at 33ºC and 8% CO 2 in DMEM containing 10% FCS, 2 mM L-glutamin, primocin (100 mg/ml, InvivoGen), and 50 U/ml IFNg (PeproTech). Once a significant number of cells had sprouted out, the aorta pieces were removed, and the remaining cells were propagated under the same culture conditions. SMC identity was confirmed by staining with a-SMA antibody. See Supplemental Data for information about biochemistry, immunofluorescence, and stimulation experiments.
Video Microscopy
Control or Dephrin-B2 cells were seeded in 35 mm glass-bottom Petri dishes (MatTek) and recorded at a 5 min lapse interval on inverted Olympus microscopes IM or IMT-2 equipped with 10Â NA 0.25 or 4Â NA 0.1 phase-contrast objective lenses. The microscopes were enclosed in Perspex environmental incubators with 37ºC temperature control, and the cells on the stage were kept in humidified stainless-steel chambers supplied with 10% CO 2 . AQM software (Kinetic Imaging) acquired time-lapse images using XCD-X700 or XCD-X710 cameras (Sony) and operated illumination shutters to minimize the exposure of the cells to illumination. Motion-analysis software (Kinetic Imaging) was used to interactively extract cell trajectories from recorded sequences. Custom-developed Mathematica software was used to evaluate and statistically test cell speed using ANOVA.
Interference Reflection Microscopy (IRM) Time-lapse IRM images of ephrin-B2-deficient or control cells in 35 mm glass-bottom Petri dishes were acquired at 30 s lapse interval on an inverted LSM 510 laser scanning confocal microscope (Carl Zeiss Ltd.) equipped with a 63Â NA 1.4 objective lens, Perspex environmental incubator with 37ºC temperature control, and humidified stainless-steel chambers supplied with 10% CO 2 . Reflection imaging was set with 633 nm laser line, 80/20 mirror instead of the main dichroic, and no emission filter.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures, Supplemental References, 6 figures, and 14 movies and can be found with this article online at http://www.cell.com/cgi/content/full/124/1/161/DC1/.
